Nancy M. Gray, Ph.D. currently serves as President, BioVentures, LLC, the technology licensing office and business incubator for the University of Arkansas for Medical Sciences (UAMS). Nancy has more than thirty years of experience in biomedical industries, including medicinal chemistry research, management of pharmaceutical research and development, and business operations. She joined UAMS from the Southern Research Institute in Birmingham, Alabama, where she was vice president for corporate development. There, she led corporate development opportunities, including mergers and acquisitions, strategic alliances, joint ventures, minority investments, technology licenses and divestitures for the life sciences, engineering, and environment and energy business. She also led the turnaround of infectious diseases contract services business, increasing revenue by $7 million and profit by $1.2 million in three years.
Prior to her time at the Southern Research Institute, Nancy worked in various executive roles at a number of companies, including Beijing Med-Pharm Corporation, Vaxinnate Corportation and Elan Corporation. In her past roles at various startups, she was responsible for authoring the business plans that successfully raised an aggregate $126 million in venture capital financing. Nancy’s research work on central nervous system diseases resulted in three products being accepted for clinical development in five years. She was also instrumental in the development of two marketed second generation antihistamines, Allegra® and Xyzal®. Nancy is the inventor on 32 issued U.S. patents and the author of 23 publications. She received her bachelor’s degree in chemistry from Bucknell University and her doctorate in medicinal chemistry from the University of Illinois.